Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Voyager Therapeutics (VYGR) Return on Capital Employed (2016 - 2025)

Voyager Therapeutics (VYGR) has disclosed Return on Capital Employed for 11 consecutive years, with 0.54% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 31.0% to 0.54% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.54% through Dec 2025, down 31.0% year-over-year, with the annual reading at 0.45% for FY2025, 19.0% down from the prior year.
  • Return on Capital Employed hit 0.54% in Q4 2025 for Voyager Therapeutics, down from 0.52% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.41% in Q1 2023 to a low of 0.65% in Q1 2022.
  • Historically, Return on Capital Employed has averaged 0.23% across 5 years, with a median of 0.27% in 2025.
  • Biggest five-year swings in Return on Capital Employed: tumbled -76bps in 2021 and later skyrocketed 106bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.53% in 2021, then grew by 3bps to 0.52% in 2022, then surged by 121bps to 0.11% in 2023, then plummeted by -313bps to 0.23% in 2024, then crashed by -134bps to 0.54% in 2025.
  • Business Quant data shows Return on Capital Employed for VYGR at 0.54% in Q4 2025, 0.52% in Q3 2025, and 0.42% in Q2 2025.